Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 13Carcinoma, Non-Small-Cell Lung 11Neoplasm Metastasis 7Brain Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Prostatic Neoplasms 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Melanoma 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Inflammatory Breast Neoplasms 2Glioma 2Central Nervous System Neoplasms 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma 2Vaginal Neoplasms 1

Interventions

trilaciclib 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Magnetic Resonance Spectroscopy 1Glucose 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Limited Stage Small Cell Lung Cancer × Surgical Procedures, Operative × Clear all
NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Not yet recruiting
348 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡